Page last updated: 2024-09-03

imatinib mesylate and Insulinoma

imatinib mesylate has been researched along with Insulinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bartosinska, B; Eickelmann, P; Gray, NS; Jain, D; Jain, R; Kauschke, SG; Lammert, E; Liu, Q; Piemonti, L; Schumann, D; Wang, J	1

Other Studies

1 other study(ies) available for imatinib mesylate and Insulinoma

Article	Year
Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets. Diabetologia, 2013, Volume: 56, Issue:6 Topics: Animals; Benzamides; Cell Line; Cell Survival; Diabetes Mellitus, Type 2; Erythropoietin; Glucose; Humans; Imatinib Mesylate; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Magnetic Resonance Spectroscopy; Mice; Mice, Transgenic; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor, EphA5; Receptors, Eph Family	2013

Article

Year

Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets.

Diabetologia, 2013, Volume: 56, Issue:6

Topics: Animals; Benzamides; Cell Line; Cell Survival; Diabetes Mellitus, Type 2; Erythropoietin; Glucose; Humans; Imatinib Mesylate; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Magnetic Resonance Spectroscopy; Mice; Mice, Transgenic; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor, EphA5; Receptors, Eph Family

2013